Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 papers


  Alzheimer's Disease

  Free Subscription

Articles published in Ann Neurol

Retrieve available abstracts of 55 articles:
HTML format

Single Articles

    March 2020
  1. STRANDBERG TE, Tienari PJ, Kivimaki M
    Vascular and Alzheimer's disease in dementia.
    Ann Neurol. 2020 Mar 10. doi: 10.1002/ana.25715.

    January 2020
  2. ZEYDAN B, Lowe VJ, Reichard RR, Przybelski SA, et al
    Imaging Biomarkers of Alzheimer's Disease in Multiple Sclerosis.
    Ann Neurol. 2020 Jan 22. doi: 10.1002/ana.25684.
    PubMed     Abstract available

  3. DESPA F, Goldstein LB, Biessels GJ
    Amylin as a Potential Link between Type 2 Diabetes and Alzheimer Disease.
    Ann Neurol. 2020 Jan 9. doi: 10.1002/ana.25668.

    November 2019
  4. HANSEEUW BJ, Scott MR, Sikkes S, Properzi M, et al
    Evolution of anosognosia in Alzheimer's disease and its relationship to amyloid.
    Ann Neurol. 2019 Nov 21. doi: 10.1002/ana.25649.
    PubMed     Abstract available

  5. GUSTAVSSON AM, van Westen D, Stomrud E, Engstrom G, et al
    Midlife atherosclerosis and development of Alzheimer's or vascular dementia.
    Ann Neurol. 2019 Nov 12. doi: 10.1002/ana.25645.
    PubMed     Abstract available

  6. WILLIAMS DM, Finan C, Schmidt AF, Burgess S, et al
    Lipid lowering and Alzheimer's disease risk: a Mendelian randomization study.
    Ann Neurol. 2019 Nov 12. doi: 10.1002/ana.25642.
    PubMed     Abstract available

  7. PRINS S, Zhuparris A, Groeneveld GJ
    The Usefulness of Plasma Amyloid as a Prescreener for the Earliest Alzheimer Pathological Changes depends on the study population.
    Ann Neurol. 2019 Nov 1. doi: 10.1002/ana.25634.

  8. VERBERK IMW, Teunissen CE, Van der Flier WM
    Reply to "The Usefulness of Plasma Amyloid as Prescreener of the earliest Alzheimer Pathological Changes depends on the study population".
    Ann Neurol. 2019 Nov 1. doi: 10.1002/ana.25633.

    October 2019
  9. JAMES BD, Wilson RS, Capuano AW, Boyle PA, et al
    Hospitalization, Alzheimer's and Related Neuropathologies, and Cognitive Decline.
    Ann Neurol. 2019 Oct 15. doi: 10.1002/ana.25621.
    PubMed     Abstract available

    September 2019
  10. MENG Y, Abrahao A, Heyn CC, Bethune AJ, et al
    Glymphatics visualization after focused ultrasound induced blood-brain barrier opening in humans.
    Ann Neurol. 2019 Sep 16. doi: 10.1002/ana.25604.
    PubMed     Abstract available

    August 2019
  11. KUMMER BR, Diaz I, Wu X, Aaroe AE, et al
    Associations between cerebrovascular risk factors and parkinson disease.
    Ann Neurol. 2019 Aug 29. doi: 10.1002/ana.25564.
    PubMed     Abstract available

  12. MARTINEZ-VALBUENA I, Valenti-Azcarate R, Amat-Villegas I, Riverol M, et al
    Amylin as a potential link between type 2 diabetes and Alzheimer's disease.
    Ann Neurol. 2019 Aug 3. doi: 10.1002/ana.25570.
    PubMed     Abstract available

    July 2019
  13. SCHULTZ A, Kloet RW, Sohrabi HR, van der Weerd L, et al
    Amyloid Imaging of Dutch-type Hereditary Cerebral Amyloid Angiopathy Carriers.
    Ann Neurol. 2019 Jul 30. doi: 10.1002/ana.25560.
    PubMed     Abstract available

  14. WHARTON W, Kollhoff AL, Gangishetti U, Verble DD, et al
    IL-9 alterations linked to Alzheimer's disease in African Americans.
    Ann Neurol. 2019 Jul 4. doi: 10.1002/ana.25543.
    PubMed     Abstract available

    June 2019
  15. LEONENKO G, Shoai M, Bellou E, Sims R, et al
    Genetic risk for Alzheimer's disease is distinct from genetic risk for amyloid deposition.
    Ann Neurol. 2019 Jun 14. doi: 10.1002/ana.25530.
    PubMed     Abstract available

  16. YANG T, Dang Y, Ostaszewski B, Mengel D, et al
    Target Engagement in an Alzheimer Trial: Crenezumab Lowers Abeta Oligomers in CSF.
    Ann Neurol. 2019 Jun 5. doi: 10.1002/ana.25513.
    PubMed     Abstract available

    March 2019
  17. WADHWANI AR, Affaneh A, Van Gulden S, Kessler JA, et al
    Neuronal Apolipoprotein E4 increases cell death and p-tau release in Alzheimer's disease.
    Ann Neurol. 2019 Mar 6. doi: 10.1002/ana.25455.
    PubMed     Abstract available

    February 2019
  18. COUGHLIN D, Xie SX, Liang M, Williams A, et al
    Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders.
    Ann Neurol. 2019;85:259-271.
    PubMed     Abstract available

    January 2019
  19. PANZA F, Lozupone M, Seripa D, Imbimbo BP, et al
    Amyloid-beta Immunotherapy for Alzheimer's Disease - Is It Now A Long Shot...?
    Ann Neurol. 2019 Jan 11. doi: 10.1002/ana.25410.
    PubMed     Abstract available

  20. GABELLE A, Jaussent I, Bouallegue FB, Lehmann S, et al
    Reduced brain amyloid burden in elderly patients with narcolepsy type 1.
    Ann Neurol. 2019;85:74-83.
    PubMed     Abstract available

    December 2018
  21. HARRISON TM, La Joie R, Maass A, Baker SL, et al
    Longitudinal tau accumulation and atrophy in aging and Alzheimer's disease.
    Ann Neurol. 2018 Dec 31. doi: 10.1002/ana.25406.
    PubMed     Abstract available

    November 2018
  22. BOYLE PA, Yu L, Leurgans SE, Wilson RS, et al
    Attributable Risk of Alzheimer's Dementia Due to Age-Related Neuropathologies.
    Ann Neurol. 2018 Nov 12. doi: 10.1002/ana.25380.
    PubMed     Abstract available

    September 2018
  23. IHARA R, Vincent BD, Baxter MR, Franklin EE, et al
    Relative neuron loss in hippocampal sclerosis of aging and Alzheimer disease.
    Ann Neurol. 2018 Sep 24. doi: 10.1002/ana.25344.
    PubMed     Abstract available

  24. VERBERK IMW, Slot RE, Verfaillie SCJ, Heijst H, et al
    Plasma amyloid as pre-screener for the earliest Alzheimer's pathological changes.
    Ann Neurol. 2018 Sep 9. doi: 10.1002/ana.25334.
    PubMed     Abstract available

    July 2018
  25. VECCHIO F, Miraglia F, Iberite F, Lacidogna G, et al
    Sustainable method for Alzheimer's prediction in Mild Cognitive Impairment: EEG connectivity and graph theory combined with ApoE.
    Ann Neurol. 2018 Jul 16. doi: 10.1002/ana.25289.
    PubMed     Abstract available

  26. ARNOLD SE, Betensky RA
    Multi-crossover randomized controlled trial designs in Alzheimer's disease.
    Ann Neurol. 2018 Jul 16. doi: 10.1002/ana.25280.
    PubMed     Abstract available

    June 2018
  27. YU L, Petyuk VA, Gaiteri C, Mostafavi S, et al
    Targeted brain proteomics uncover multiple pathways to Alzheimer's dementia.
    Ann Neurol. 2018 Jun 16. doi: 10.1002/ana.25266.
    PubMed     Abstract available

    March 2018
  28. SHEIKH-BAHAEI N, Sajjadi SA, Manavaki R, McLean M, et al
    PET-guided MR Spectroscopy in Alzheimer's disease.
    Ann Neurol. 2018 Mar 8. doi: 10.1002/ana.25202.
    PubMed     Abstract available

    February 2018
  29. GOETZL EJ, Schwartz JB, Abner EL, Jicha GA, et al
    High complement levels in astrocyte-derived exosomes of Alzheimer's disease.
    Ann Neurol. 2018 Feb 6. doi: 10.1002/ana.25172.
    PubMed     Abstract available

  30. TAN CH, Desikan RS
    Interpreting Alzheimer's disease polygenic scores.
    Ann Neurol. 2018 Feb 2. doi: 10.1002/ana.25164.

    January 2018
  31. DONG Y, Lagarde J, Xicota L, Corne H, et al
    Neutrophil hyperactivation correlates with Alzheimer's disease progression.
    Ann Neurol. 2018 Jan 25. doi: 10.1002/ana.25159.
    PubMed     Abstract available

  32. WHITWELL JL, Graff-Radford J, Tosakulwong N, Weigand SD, et al
    [(18) F]AV-1451 clustering of entorhinal and cortical uptake in Alzheimer's disease.
    Ann Neurol. 2018 Jan 11. doi: 10.1002/ana.25142.
    PubMed     Abstract available

  33. BAGI Z, Brandner DD, Le P, McNeal DW, et al
    Vasodilator dysfunction and oligodendrocyte dysmaturation in aging white matter.
    Ann Neurol. 2018;83:142-152.
    PubMed     Abstract available

  34. BOYLE PA, Yu L, Wilson RS, Leurgans SE, et al
    Person-specific contribution of neuropathologies to cognitive loss in old age.
    Ann Neurol. 2018;83:74-83.
    PubMed     Abstract available

  35. LUCEY BP, Hicks TJ, McLeland JS, Toedebusch CD, et al
    Effect of sleep on overnight cerebrospinal fluid amyloid beta kinetics.
    Ann Neurol. 2018;83:197-204.
    PubMed     Abstract available

    November 2017
  36. CHRISTOPHER L, Napolioni V, Khan RR, Han SS, et al
    A variant in PPP4R3A protects against Alzheimer-related metabolic decline.
    Ann Neurol. 2017 Nov 11. doi: 10.1002/ana.25094.
    PubMed     Abstract available

    October 2017
  37. VEMURI P, Lesnick TG, Przybelski SA, Knopman DS, et al
    Age, Vascular Health, and Alzheimer's disease Biomarkers in an Elderly Sample.
    Ann Neurol. 2017 Oct 10. doi: 10.1002/ana.25071.
    PubMed     Abstract available

    September 2017
  38. BOROS BD, Greathouse KM, Gentry EG, Curtis KA, et al
    Dendritic spines provide cognitive resilience against Alzheimer's disease.
    Ann Neurol. 2017 Sep 16. doi: 10.1002/ana.25049.
    PubMed     Abstract available

  39. TAN CH, Hyman BT, Tan JJX, Hess CP, et al
    Polygenic hazard scores in preclinical Alzheimer disease.
    Ann Neurol. 2017;82:484-488.
    PubMed     Abstract available

    August 2017
  40. IRWIN DJ, Lleo A, Xie SX, McMillan CT, et al
    Ante mortem cerebrospinal fluid tau levels correlate with postmortem tau pathology in frontotemporal lobar degeneration.
    Ann Neurol. 2017;82:247-258.
    PubMed     Abstract available

    July 2017
  41. ESCOTT-PRICE V, Myers AJ, Huentelman M, Hardy J, et al
    Polygenic Risk Score Analysis of Pathologically Confirmed Alzheimer's Disease.
    Ann Neurol. 2017 Jul 20. doi: 10.1002/ana.24999.
    PubMed     Abstract available

    June 2017
  42. VASSILAKI M, Christianson TJ, Mielke MM, Geda YE, et al
    Neuroimaging biomarkers and impaired olfaction in cognitively normal individuals.
    Ann Neurol. 2017;81:871-882.
    PubMed     Abstract available

    May 2017
  43. MARTISKAINEN H, Herukka SK, Stancakova A, Paananen J, et al
    Decreased plasma beta-amyloid in the Alzheimer's disease APP A673T variant carriers.
    Ann Neurol. 2017 May 26. doi: 10.1002/ana.24969.
    PubMed     Abstract available

  44. TIJMS BM, Bertens D, Slot RE, Gouw AA, et al
    Low normal cerebrospinal fluid Abeta42 levels predict clinical progression in nondemented subjects.
    Ann Neurol. 2017;81:749-753.
    PubMed     Abstract available

    April 2017
  45. MENG Y, Volpini M, Black S, Lozano AM, et al
    Focused ultrasound as a novel strategy for Alzheimer's disease therapeutics.
    Ann Neurol. 2017 Apr 10. doi: 10.1002/ana.24933.
    PubMed     Abstract available

  46. HANSEEUW BJ, Betensky RA, Schultz AP, Papp KV, et al
    Fluorodeoxyglucose metabolism associated with tau-amyloid interaction predicts memory decline.
    Ann Neurol. 2017;81:583-596.
    PubMed     Abstract available

  47. ABNER EL, Kryscio RJ, Schmitt FA, Fardo DW, et al
    Outcomes after diagnosis of mild cognitive impairment in a large autopsy series.
    Ann Neurol. 2017;81:549-559.
    PubMed     Abstract available

    March 2017
  48. SPINELLI EG, Mandelli ML, Miller ZA, Santos-Santos MA, et al
    Typical and atypical pathology in primary progressive aphasia variants.
    Ann Neurol. 2017;81:430-443.
    PubMed     Abstract available

    December 2016
  49. MARQUIE M, Normandin MD, Meltzer AC, Siao Tick Chong M, et al
    Pathologic correlations of [F-18]-AV-1451 imaging in non-Alzheimer tauopathies.
    Ann Neurol. 2016 Dec 20. doi: 10.1002/ana.24844.
    PubMed     Abstract available

    November 2016
  50. KANTARCI K, Lowe VJ, Boeve BF, Senjem ML, et al
    AV-1451 Tau and beta-Amyloid PET Imaging in Dementia with Lewy Bodies.
    Ann Neurol. 2016 Nov 18. doi: 10.1002/ana.24825.
    PubMed     Abstract available

    October 2016
  51. ALBERS AD, Asafu-Adjei J, Delaney MK, Kelly KE, et al
    Episodic Memory of Odors Stratifies Alzheimer Biomarkers in Normal Elderly.
    Ann Neurol. 2016 Oct 1. doi: 10.1002/ana.24792.
    PubMed     Abstract available

  52. VOSSEL KA, Ranasinghe KG, Beagle AJ, Mizuiri D, et al
    Incidence and Impact of Subclinical Epileptiform Activity in Alzheimer's Disease.
    Ann Neurol. 2016 Oct 1. doi: 10.1002/ana.24794.
    PubMed     Abstract available

    August 2016
  53. BAYKARA E, Gesierich B, Adam R, Tuladhar AM, et al
    A novel imaging marker for small vessel disease based on skeletonization of white matter tracts and diffusion histograms.
    Ann Neurol. 2016 Aug 12. doi: 10.1002/ana.24758.
    PubMed     Abstract available

    July 2016
  54. TIRABOSCHI P, Corso A, Guerra UP, Nobili F, et al
    123 I-FP-CIT SPECT and 123 I-MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from other dementias: a comparative study.
    Ann Neurol. 2016 Jul 11. doi: 10.1002/ana.24717.
    PubMed     Abstract available

    April 2016
  55. MATIAS-GUIU JA, Cabrera-Martin MN, Oreja-Guevara C, Carreras JL, et al
    PiB and other amyloid-PET tracers for the study of white matter and multiple sclerosis.
    Ann Neurol. 2016 Apr 21. doi: 10.1002/ana.24666.

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.